Key result
Thrombin-cleaved PAR4 exhibited a 2-fold increase in t 1/2 values for four histidine residues, demonstrating decreased solvent accessibility upon thrombin treatment.
Why the study?
Numerous studies have focused on signaling pathways mediated by protease-activated receptors, but the structural basis for initiation of these pathways was unknown.
Answers are grounded in this paper and cite their sources.
This study establishes a strategy for PAR4 expression and purification, providing the first biophysical evidence of conformational changes during its tethered ligand activation mechanism.
Protease-activated receptors (PARs) are G-protein-coupled receptors that are activated by proteolysis of the N-terminus, which exposes a tethered ligand that interacts with the receptor. Numerous studies have focused on the signaling pathways mediated by PARs. However, the structural basis for initiation of these pathways is unknown. Here, we describe a strategy for the expression and purification of PAR4. This is the first PAR family member to be isolated without stabilizing modifications for biophysical studies. We monitored PAR4 activation with histidine hydrogen–deuterium exchange. PAR4 has nine histidines that are spaced throughout the protein, allowing a global view of solvent accessible and nonaccessible regions. Peptides containing each of the nine His residues were used to determine the t 1/2 for each His residue in apo or thrombin-activated PAR4. The thrombin-cleaved PAR4 exhibited a 2-fold increase ( p > 0.01) in t 1/2 values observed for four histidine residues (His 180, His 229, His 240, and His 380 ), demonstrating that these regions have decreased solvent accessibility upon thrombin treatment. In agreement, thrombin-cleaved PAR4 also was resistant to thermolysin digestion. In contrast, the rate of thermolysin proteolysis following stimulation with the PAR4 activation peptide was the same as that of unstimulated PAR4. Further analysis showed the C-terminus is protected in thrombin-activated PAR4 compared to uncleaved or agonist peptide-treated PAR4. The studies described here are the first to examine the tethered ligand activation mechanism for a PAR family member biophysically and shed light on the overall conformational changes that follow activation of PARs by a protease.
No takes yet. Share an insight, caveat, or question.
Fuente et al. (2020) studied this question. Thrombin activation vs. Apo or unstimulated PAR4 was evaluated on t 1/2 for histidine residues (solvent accessibility) (2-fold increase, p=> 0.01). Thrombin-cleaved PAR4 exhibited a 2-fold increase in t 1/2 values for four histidine residues, demonstrating decreased solvent accessibility upon thrombin treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: